SLAS2024 International Conference and Exhibition
February 3 - 7, 2024
Share this event
The Society for Laboratory Automation and Screening (SLAS) is an international professional society of academic, industry and government researchers as well as developers and providers of laboratory automation and screening technology. An important part of their mission is connecting laboratory technology providers—like us here at Beckman Coulter Life Sciences—with you.
The SLAS International Conference and Exhibition is their flagship event where thousands of scientists, researchers, academics, and government lab professionals from around the world will gather to learn, share and collaborate.
SLAS2024 takes place February 3 – 7 in Boston. We’re a proud sponsor of the event and look forward to seeing you there! Our booth will look a little different this year—we’re teaming up with fellow Danaher operating companies Molecular Devices, SCIEX, Leica Microsystems, IDBS, Integrated DNA Technologies, and Phenomenex in one cohesive booth showcasing integrated workflow solutions for high-throughput screening, 3D biology, plasmid generation, analytical applications and cell line development.
Integrating & Automating Your Lab, One Workflow at a Time
We look forward to seeing you at SLAS2024 and hearing all about the discoveries you’ve made in the lab over the past year. We’ve been hard at work, too, and are excited to introduce you to solutions that can help you:
- Reduce assay volumes and consumables use
- Use massive data sets to design and screen complex plasmid constructs
- Enhance and accelerate cell line development culture and clone ranking
- Screen microbial strains, cultivation media and bioprocess conditions faster
- Reduce gene assembly cost
A Sneak Peek at What Will be on Display
Featuring state-of-the-art automation technology, Biomek i-Series Automated Workstations offer unparalleled efficiency and versatility, making it a go-to solution for the most demanding laboratory workflows like next-generation sequencing (NGS), synthetic biology, genomic research, proteomics, drug discovery, sample management, and functional screening. The Biomek i7 Automated Workstation is designed to optimize dependability and walk-away time in mid- to high-throughput labs.
Unlike traditional liquid handlers, Echo acoustic liquid handlers use sound energy to precisely transfer liquid—without contact, pipette tips, nozzles or tubing.
The Echo 655T liquid handler enables high-throughput, acoustic transfer of samples and reagents in volumes as low as 2.5 nL.
Designed specifically for biochemical and genomic assays, the Echo 525 Liquid Handler provides the accuracy and precision you need to improve assay reliability and data quality.
Access Integrated Systems
The Access Single Robot System (SRS) and the Access Dual Robot System (DRS) are compact, modular, high-capacity, and high-throughput platforms, designed and optimized for the use of Echo Liquid Handlers in sample management workflows. They enable the production of assay-ready plates from acoustic sample tubes. The systems combine industry-leading devices and software with ergonomic and environment management options to provide a complete, easy-to-use, store-to-assay sample management solution.
Access Solutions Group: Translating Science into Systems
Our Access Solutions Group is a dedicated team that has delivered more than 8,000 tailored automation solutions to research groups around the world. We consult with you to design scalable custom solutions that automate your assays, from entry-level workstations to comprehensive robotic systems, creating workflow security for your needs in your evolving quest for answers. Deploying our extensive library of software and third-party instrument integrations with efficient resource allocation and data management, we help you optimize the direct use of our Biomek Automated Workstations and Echo Acoustic Liquid Handlers to automate your unique workflow.
BioLector XT Microbioreactor & Biomek i5 Liquid Handler Integration
This unique automated screening platform integrates the high-throughput cultivation and online monitoring capability of the BioLector XT microbioreactor with the precise liquid handling of a Biomek i5 Automated Workstation.
Talks & Tutorials
This year, SLAS has lined up more than 150 scientific talks spanning nine educational tracks within life sciences, technology and laboratory automation.
We’re looking forward to sharing the stage with a number of insightful guest speakers during our tutorial and spotlight sessions.
Here’s a schedule of events for the week:
Monday, February 5
Tim Read, Ph.D.,
Co-Founder & Chief Technology Officer,
Development of a Global Reporter on Transcript Abundance (GRETA) for Drug Discovery and Development
12:00 – 1:00 p.m. | Tutorial Room 104B
Arpeggio Biosciences has developed an automated RNA sequencing platform capable of measuring genome-wide transcript levels for less than $2 per sample. The platform is ideal for measuring the transcriptomic responses to thousands of individual compounds, allowing rapid definition of each compound's mechanism of action. They have successfully used the platform as part of compound screening cascades as well as part of a hit-to-lead campaign resulting in a first-in-class orally bioavailable GPX4 inhibitor for the treatment of drug-resistant cancers. GRETA not only quantifies the on-target effects of a compound, but also the diverse off-target effects of a compound—from a single experiment—allowing rapid prioritization of compounds for further exploration.
Tuesday, February 6
Co-Founder and Chief Operating Officer,
Z-X-Y: Integrating Acoustic Dispensing with Droplet Microfluidics for Accelerating Gene Editing Workflows
2:00 – 2:20 p.m. | Solutions Spotlight Theater 1290
DropGenie has developed a novel microfluidic platform to enable genome-wide arrayed CRISPR screening in primary cells, addressing challenges in precision medicine. This platform minimizes the need for a large number of cells per edit, reducing cellular input requirements from millions to thousands, while maintaining high efficiency and without compromising viability. It can deliver various payloads, such as mRNA, RNP, and DNA, efficiently without affecting cell function.
The platform is versatile, working effectively with different primary cell types, including immune cell subsets, stem cells, and other complex cellular systems. The editing cartridge integration with automation enables the execution of thousands of edits per day without human intervention, making drug discovery more cost-effective and efficient at the single-donor level. In this talk, they’ll present a workflow that uses the Echo 655T acoustic liquid handler as well as the Biomek i7 hybrid liquid handler with the DropGenie platform to deliver on the promise of low-volume, high-throughput discovery.
©2024 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the Stylized Logo, and Beckman Coulter product and service marks mentioned herein, including Biomek, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. ECHO is a trademark or registered trademark of Labcyte Inc. in the United States and other countries. Valita, Valita Titer and the ValitaCell logo are trademarks or registered trademarks of ValitaCell in the United States and other countries. Labcyte Inc. and ValitaCell are Beckman Coulter Companies. All other trademarks are the property of their respective owners.